Article

Pinpointing neurologic dysfunction in fundus photographs using deep learning analysis

Author(s):

Deep learning analysis of fundus photographs has the potential to assess neurologic dysfunction in individuals with Parkinson’s disease.

Doctor holding an image of the brain (Image Credit: AdobeStock/ipuwadol)

(Image Credit: AdobeStock/ipuwadol)

Sangil Ahn, BS, and colleagues reported that deep learning analysis of fundus photographs has the potential to assess neurologic dysfunction in individuals with Parkinson’s disease (PD).1 He is from the Department of Electrical and Computer Engineering, Sungkyunkwan University, Suwon, Republic of Korea.

The ability to assess neurologic disabilities in this manner would eliminate the need for complex neurologic testing by using a noninvasive widely available technology to assess patients, the investigators explained.

In their study, the goal was to develop an algorithm that can predict Hoehn and Yahr (H-Y) scale and Unified Parkinson’s Disease Rating Scale part III (UPDRS-III) scores using fundus photography in patients with PD.

Ahn and colleagues analyzed the fundus photographs of study patients with Parkinson’s disease and participants with atypical motor abnormalities that was not PD who visited the neurology department of Kangbuk Samsung Hospital from October 7, 2020, to April 30, 2021. They developed a convolutional neural network to predict both the H-Y scale and UPDRS-III scores based on fundus photography findings and the participants’ demographic characteristics, they explained.

The study population was comprised of 266 patients with PD (134 men; mean age, 70.8 years), and 349 individuals with non-PD atypical motor abnormalities (236 women; mean age, 70.7 years). The investigators analyzed 539 fundus images from the PD patients.

For the internal validation data set, the sensitivity values were 83.23% (95% confidence interval [CI], 82.07%-84.38%) and 82.61% (95% CI, 81.38%-83.83%) for the H-Y scale and UPDRS-III scores, respectively. The respective specificity values were 66.81% (95% CI, 64.97%-68.65%) and 65.75% (95% CI, 62.56%-68.94%).

For the external validation data set, the sensitivity and specificity were 70.73% (95% CI, 66.30%-75.16%) and 66.66% (95% CI, 50.76%-82.25%), respectively.

The calculated area under the ROC curve and accuracy were 0.67 (95% CI, 0.55-0.79) and 70.45% (95% CI, 66.85%-74.04%), respectively.

The investigators commented, “This decision analytical model reveals amalgamative insights into the neurologic dysfunction among PD patients by providing information on how to apply a deep learning method to evaluate the association between the retina and brain. Study data may help clarify recent research findings regarding dopamine pathologic cascades between the retina and brain among patients with PD; however, further research is needed to expand the clinical implication of this algorithm.”

Reference:
1. Ahn S, Shin J, Song SJ, et al. Neurologic dysfunction assessment in Parkinson disease based on fundus photographs using deep learning. JAMA Ophthalmol. 2023;141(3):234-240. doi:10.1001/jamaophthalmol.2022.5928

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.